Smoked cannabis as an adjunctive second-line therapy to treat chronic peripheral neuropathy can be both effective and cost-effective, suggests a new study that used a computer simulation model to simulate its use in one million patients.

Smoked cannabis as an adjunctive second-line therapy to treat chronic peripheral neuropathy can be both effective and cost-effective, suggests a new study that used a computer simulation model to simulate its use in one million patients.: http://bit.ly/2D23tYD Read more... http://bit.ly/2TkfiA1